查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1949462

藥用輔料市場－全球產業規模、佔有率、趨勢、機會及預測（依產品、功能、劑型、地區及競爭格局分類，2021-2031年）

Pharmaceutical Excipients Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Functionality, By Formulation, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球藥用輔料市場預計將從 2025 年的 89.7 億美元成長到 2031 年的 121.9 億美元，複合年成長率為 5.25%。

這些藥理學上惰性的物質與活性成分配製在一起，以促進藥物遞送、提高穩定性並確保劑量均勻性。市場成長的主要驅動力是慢性病盛行率的上升和全球人口老化，這推動了對大規模生產的固態劑型的需求。此外，學名藥產業的持續擴張也是推動銷售成長的關鍵因素。根據美國可及藥品協會（Association for Accessible Medicines）預測，到2024年，學名藥和生物相似藥將占美國處方處方箋的90%，這表明經濟有效的治療方法在推動原料藥需求方面發揮關鍵作用。

市場概覽
預測期 2027-2031
市場規模：2025年 89.7億美元
市場規模：2031年 121.9億美元
複合年成長率：2026-2031年 5.25%
成長最快的細分市場 有機化學品
最大的市場 北美洲

阻礙市場擴張的一大挑戰是監管合規和供應鏈透明度日益複雜的問題。製造商必須遵守嚴格的雜質含量標準，這需要進行廣泛的風險評估和原料可追溯性管理。這些嚴格的要求往往會導致營運成本增加和核准流程冗長，給供應商帶來障礙，他們必須投入大量資金才能滿足世界各地衛生監管機構不斷變化的安全標準。

市場促進因素

生物製藥製造業的快速擴張推動了對高純度、功能性輔料的需求，這些輔料對於腸外給藥至關重要。生物製藥，例如單株抗體，需要特殊的穩定劑和界面活性劑來維持其分子結構，這使得市場關注點從傳統的固態製劑填充劑轉向了先進的製劑成分。這種向複雜治療方法的結構趨勢正在迅速加速。根據2024年9月發布的CPHI 2024年度報告，該產業正處於一個轉折點，預計複雜分子藥物的核准核准將超過小分子藥物。 2023年核准的55種新藥中，有17種是生物製藥，9種是胜肽類或寡核苷酸療法，這便是一個例證。這項創新得到了大量資金的支持；根據歐洲製藥工業協會聯合會（EFPIA）估計，2024年歐洲以研發為基礎的製藥業將在研發方面投入約550億歐元，這將直接推動這些新型藥物遞送系統的開發平臺。

隨著製藥公司擴大將生產外包以最佳化成本並獲取專業技術，醫藥契約製造市場的擴張也推動了成長。合約研發生產機構（CDMO）作為中央採購機構的角色日益強化，它們需要大量符合多種標準的輔料以滿足不同的國際監管標準。這種採購集中化也體現在主要服務供應商的財務表現中。根據龍沙公司於2024年3月發布的2023年度報告，該公司銷售額達67億瑞士法郎，年增7.9%，主要得益於其生物製劑和小分子藥物部門的強勁表現。隨著CDMO擴大營運規模，它們需要可靠的、用途廣泛的輔料供應鏈，以實現各種劑型的高效生產。

市場挑戰

對監管合規性和供應鏈透明度日益成長的要求，對全球藥用輔料市場構成了重大阻礙因素。隨著國際衛生機構對雜質含量實施更嚴格的限制，並要求原料可追溯性，輔料生產商的工作量急劇增加。這種合規壓力迫使供應商將大量資源投入持續的風險評估和驗證通訊協定中，而不是擴大產能。因此，將合規原料推向市場所需的時間和資金都在增加，這造成了許多障礙，對小規模供應商的影響尤其嚴重，並降低了整個供應鏈的流動性。

這些監管瓶頸直接阻礙了市場成長，擾亂了基本藥物原料的供應，導致生產中斷。據美國衛生系統藥劑師協會 (ASHP) 稱，到 2024 年，美國醫療保健行業報告的藥品短缺數量將達到創紀錄的 323 種，這場危機部分歸因於持續存在的生產品質挑戰和監管障礙。下游製造業的這種不穩定性限制了對輔料的穩定需求，因為成品製造商在合規性問題日益增多的情況下無法維持穩定的生產計劃。

市場趨勢

隨著越來越多的生產商尋求簡化口服固體製劑的生產流程並降低配方複雜性，多功能和共加工輔料的應用正在加速。先進的預配方系統，例如即用型薄膜包衣和高級粘合劑，無需多階段混合工藝，從而提高了運營效率並最大限度地減少了批次間差異。這種對生產最佳化的追求正促使主要供應商擴大生產規模，以確保這些關鍵成分的穩定供應。根據2025年7月《印度化學新聞》一篇報導「Colorcon在馬來西亞開設新的薄膜包衣生產工廠」的文章報道，該公司開設了一座佔地20萬平方英尺的新生產工廠，以滿足該地區對先進包衣系統和功能性輔料日益成長的需求。

同時，受患者對非動物性配方偏好的轉變以及嚴格的飲食限制的推動，市場正經歷著向植物來源、潔淨標示成分的重大轉變。這一趨勢迫使輔料供應商從傳統的動物性成分（例如明膠）轉向纖維素替代品（例如羥丙基纖維素，HPMC），這些替代品性能相當，但更易於被消費者接受。為了體現這項策略調整，該公司宣布分階段投資2億美元，新建一座能夠生產適合素食者的硬殼膠囊的工廠，以滿足北美市場對空膠囊潔淨標示製劑形式日益成長的需求。這項消息已在2025年10月發表於《營養展望》雜誌的一篇文章中披露，該文章報導「ACG將投資2億美元建設美國首個空膠囊生產工廠」。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球藥用輔料市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品種類（有機化學品、油脂化學品（脂醇類、金屬硬脂酸鹽、甘油等）、碳水化合物（糖、醇、澱粉）、石油化學品、蛋白質、磷酸鈣、金屬氧化物、鹽、碳酸鈣、硫酸鈣等）
    • 依功能分類（填充劑/稀釋劑、懸浮劑/黏度調節劑、包衣劑、粘合劑、調味劑/甜味劑、崩壞、著色劑、潤滑劑/滑移劑、防腐劑、乳化劑、其他）
    • 依劑型分類（口服製劑、錠劑、膠囊（硬膠囊、軟膠囊）、液體、外用製劑、注射劑、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美藥用輔料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲藥用輔料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區藥用輔料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲藥用輔料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲藥用輔料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球藥用輔料市場：SWOT分析

第14章 波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • BASF SE
  • Origin Instruments Corporation
  • Ashland Global Holdings
  • DuPont de Nemours, Inc.
  • Roquette Feres
  • Evonik Industries AG
  • Associated British Foods
  • Archer Daniels Midland Company
  • Lubrizol Corporation
  • Croda International
  • Kerry Group

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20063

The Global Pharmaceutical Excipients Market is projected to increase from USD 8.97 Billion in 2025 to USD 12.19 Billion by 2031, reflecting a CAGR of 5.25%. These pharmacologically inactive substances are formulated alongside active pharmaceutical ingredients to facilitate drug delivery, improve stability, and ensure dosage consistency. Market growth is primarily supported by the rising prevalence of chronic diseases and an aging global population, which drive the demand for high-volume solid dosage medications. Additionally, the sustained expansion of the generic drug sector serves as a vital catalyst for volume growth. According to the Association for Accessible Medicines, generic and biosimilar medicines accounted for 90 percent of all prescriptions filled in the United States in 2024, demonstrating the critical role of cost-effective therapies in driving the demand for bulk formulation ingredients.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 8.97 Billion
Market Size 2031USD 12.19 Billion
CAGR 2026-20315.25%
Fastest Growing SegmentOrganic Chemicals
Largest MarketNorth America

A significant challenge hindering market expansion is the growing complexity of regulatory compliance and supply chain transparency. Manufacturers are subject to rigorous standards regarding impurity limits, which necessitate extensive risk assessments and raw material tracing. These stringent requirements often result in higher operational costs and extended approval timelines, creating barriers for suppliers who must invest heavily to meet the evolving safety expectations of global health authorities.

Market Driver

The rapid expansion of the biopharmaceutical manufacturing sector is fueling demand for high-purity, functional excipients essential for parenteral delivery. Biologics, such as monoclonal antibodies, require specialized stabilizers and surfactants to maintain molecular integrity, shifting the market focus from traditional solid dosage fillers to advanced formulation ingredients. This structural trend toward complex therapies is accelerating rapidly; according to CPHI's 'Annual Report 2024' from September 2024, the industry is undergoing a major shift where approvals for complex molecules are projected to surpass small molecules, highlighted by the authorization of 17 biologics and nine peptide or oligonucleotide therapies among the 55 new drugs approved in 2023. This innovation is underpinned by substantial capital allocation; according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the research-based pharmaceutical industry invested an estimated €55,000 million in R&D in Europe in 2024, directly fueling the development pipeline for these novel drug delivery systems.

The expansion of the pharmaceutical contract manufacturing market further propels growth as drug developers increasingly outsource production to optimize costs and access specialized capabilities. Contract Development and Manufacturing Organizations (CDMOs) are becoming centralized purchasers, often requiring large volumes of multi-compendial excipients to meet diverse global regulatory standards. This consolidation of procurement is evident in the financial performance of leading service providers; according to Lonza's 'Annual Report 2023' released in March 2024, the company reported sales of CHF 6.7 billion, achieving a sales growth of 7.9 percent primarily driven by strong performance in its Biologics and Small Molecules divisions. As CDMOs expand their operational footprint, they necessitate a reliable supply chain of versatile excipients that facilitate streamlined manufacturing across varying dosage forms.

Market Challenge

The increasing complexity of regulatory compliance and supply chain transparency acts as a significant restraint on the Global Pharmaceutical Excipients Market. As international health authorities enforce stricter limits on impurities and demand rigorous raw material traceability, excipient manufacturers face a steep escalation in operational burdens. This compliance pressure forces suppliers to allocate substantial resources toward continuous risk assessments and validation protocols rather than production capacity expansion. Consequently, the time and capital required to bring compliant ingredients to market increase, creating barriers that disproportionately impact smaller suppliers and reduce the overall fluidity of the supply chain.

These regulatory bottlenecks directly impede market growth by disrupting the availability of essential formulation ingredients, leading to production stalls. According to the American Society of Health-System Pharmacists, the U.S. healthcare sector reported an all-time high of 323 active drug shortages in 2024, a crisis partially attributed to persistent manufacturing quality challenges and regulatory hurdles. This instability in the downstream manufacturing sector restricts the consistent volume demand for excipients, as finished dose manufacturers cannot maintain steady production schedules amidst such heightened compliance-driven disruptions.

Market Trends

The adoption of multifunctional and co-processed excipients is intensifying as manufacturers seek to streamline oral solid dosage production and reduce formulation complexity. These advanced, pre-formulated systems-such as ready-to-use film coatings and high-functionality binders-eliminate the need for multi-step blending, thereby enhancing operational efficiency and minimizing batch variability. This drive for manufacturing optimization is prompting major suppliers to expand their production footprints to ensure a reliable supply of these critical ingredients. According to Indian Chemical News in the July 2025 article 'Colorcon opens new film coating manufacturing facility in Malaysia', the company inaugurated a new 200,000 square-foot production plant specifically designed to support the growing regional demand for advanced coating systems and functional excipients.

Concurrently, the market is witnessing a decisive transition toward plant-based and clean label ingredients, driven by evolving patient preferences for non-animal derived formulations and strict dietary requirements. This shift is compelling excipient providers to pivot away from traditional animal-sourced materials like gelatin in favor of cellulose-based alternatives, such as HPMC, which offer comparable performance with broader consumer acceptance. Reflecting this strategic realignment, according to Nutritional Outlook in the October 2025 article 'ACG will invest $200 million in its first empty-capsule manufacturing facility in the US', the company announced a phased capital allocation of $200 million to establish a new facility capable of producing vegetarian hard-shell capsules to meet the rising need for clean label delivery forms in North America.

Key Market Players

  • BASF SE
  • Origin Instruments Corporation
  • Ashland Global Holdings
  • DuPont de Nemours, Inc.
  • Roquette Feres
  • Evonik Industries AG
  • Associated British Foods
  • Archer Daniels Midland Company
  • Lubrizol Corporation
  • Croda International
  • Kerry Group

Report Scope

In this report, the Global Pharmaceutical Excipients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Excipients Market, By Product

  • Organic Chemicals
  • Oleochemicals(Fatty Alcohols, Metal Stearates, Glycerin, Other)
  • Carbohydrates(Sugars, Alcohol, Starches)
  • Petrochemicals
  • Proteins
  • Calcium Phosphate
  • Metal Oxides
  • Halites
  • Calcium Carbonate
  • Calcium Sulphate
  • Others

Pharmaceutical Excipients Market, By Functionality

  • Fillers & Diluents
  • Suspending & Viscosity Agents
  • Coating Agents
  • Binders
  • Flavoring Agents & Sweeteners
  • Disintegrants
  • Colorants
  • Lubricants & Glidants
  • Preservatives
  • Emulsifying Agents
  • Others

Pharmaceutical Excipients Market, By Formulation

  • Oral Formulations
  • Tablets
  • Capsules(Hard-gelatin Capsules, Soft-gelatin Capsules)
  • Liquid Formulations
  • Topical Formulations
  • Parenteral Formulations
  • Other

Pharmaceutical Excipients Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Excipients Market.

Available Customizations:

Global Pharmaceutical Excipients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Excipients Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Organic Chemicals, Oleochemicals(Fatty Alcohols, Metal Stearates, Glycerin, Other), Carbohydrates(Sugars, Alcohol, Starches), Petrochemicals, Proteins, Calcium Phosphate, Metal Oxides, Halites, Calcium Carbonate, Calcium Sulphate, Others)
    • 5.2.2. By Functionality (Fillers & Diluents, Suspending & Viscosity Agents, Coating Agents, Binders, Flavoring Agents & Sweeteners, Disintegrants, Colorants, Lubricants & Glidants, Preservatives, Emulsifying Agents, Others)
    • 5.2.3. By Formulation (Oral Formulations, Tablets, Capsules(Hard-gelatin Capsules, Soft-gelatin Capsules), Liquid Formulations, Topical Formulations, Parenteral Formulations, Other)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Pharmaceutical Excipients Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Functionality
    • 6.2.3. By Formulation
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pharmaceutical Excipients Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Functionality
        • 6.3.1.2.3. By Formulation
    • 6.3.2. Canada Pharmaceutical Excipients Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Functionality
        • 6.3.2.2.3. By Formulation
    • 6.3.3. Mexico Pharmaceutical Excipients Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Functionality
        • 6.3.3.2.3. By Formulation

7. Europe Pharmaceutical Excipients Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Functionality
    • 7.2.3. By Formulation
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pharmaceutical Excipients Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Functionality
        • 7.3.1.2.3. By Formulation
    • 7.3.2. France Pharmaceutical Excipients Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Functionality
        • 7.3.2.2.3. By Formulation
    • 7.3.3. United Kingdom Pharmaceutical Excipients Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Functionality
        • 7.3.3.2.3. By Formulation
    • 7.3.4. Italy Pharmaceutical Excipients Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Functionality
        • 7.3.4.2.3. By Formulation
    • 7.3.5. Spain Pharmaceutical Excipients Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Functionality
        • 7.3.5.2.3. By Formulation

8. Asia Pacific Pharmaceutical Excipients Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Functionality
    • 8.2.3. By Formulation
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Pharmaceutical Excipients Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Functionality
        • 8.3.1.2.3. By Formulation
    • 8.3.2. India Pharmaceutical Excipients Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Functionality
        • 8.3.2.2.3. By Formulation
    • 8.3.3. Japan Pharmaceutical Excipients Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Functionality
        • 8.3.3.2.3. By Formulation
    • 8.3.4. South Korea Pharmaceutical Excipients Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Functionality
        • 8.3.4.2.3. By Formulation
    • 8.3.5. Australia Pharmaceutical Excipients Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Functionality
        • 8.3.5.2.3. By Formulation

9. Middle East & Africa Pharmaceutical Excipients Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Functionality
    • 9.2.3. By Formulation
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Pharmaceutical Excipients Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Functionality
        • 9.3.1.2.3. By Formulation
    • 9.3.2. UAE Pharmaceutical Excipients Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Functionality
        • 9.3.2.2.3. By Formulation
    • 9.3.3. South Africa Pharmaceutical Excipients Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Functionality
        • 9.3.3.2.3. By Formulation

10. South America Pharmaceutical Excipients Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Functionality
    • 10.2.3. By Formulation
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pharmaceutical Excipients Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Functionality
        • 10.3.1.2.3. By Formulation
    • 10.3.2. Colombia Pharmaceutical Excipients Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Functionality
        • 10.3.2.2.3. By Formulation
    • 10.3.3. Argentina Pharmaceutical Excipients Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Functionality
        • 10.3.3.2.3. By Formulation

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Pharmaceutical Excipients Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. BASF SE
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Origin Instruments Corporation
  • 15.3. Ashland Global Holdings
  • 15.4. DuPont de Nemours, Inc.
  • 15.5. Roquette Feres
  • 15.6. Evonik Industries AG
  • 15.7. Associated British Foods
  • 15.8. Archer Daniels Midland Company
  • 15.9. Lubrizol Corporation
  • 15.10. Croda International
  • 15.11. Kerry Group

16. Strategic Recommendations

17. About Us & Disclaimer